Results 81 to 90 of about 1,119 (155)

DEVELOPING AN IMMUNOMODULATORY STRATEGY USING BIOPHYSICAL CUES TO MODULATE MACROPHAGE PHENOTYPE FOR FRACTURE HEALING AND BONE REGENERATION [PDF]

open access: yes
Chronic inflammation is a major cause of the pathogenesis of musculoskeletal diseases such as fragility, fracture, and nonunion. Studies have shown that modulating the immune phenotype of macrophages from proinflammatory to pro-healing can heal ...
Suresh Kumar, Harshini
core   +2 more sources

Insights on Advances in 3D Bioprinting for Peripheral Nerve Regeneration

open access: yesAdvanced Therapeutics, Volume 8, Issue 5, May 2025.
Peripheral nerve injury is a common condition due to trauma that significantly impacts the life of the affected individual. This review explores the anatomy, classification, and pathophysiology of peripheral nerve injuries. It also discusses various types of nerve conduits and presents a detailed review of 3D bioprinted nerve conduits used in both in ...
Nasera Rizwana   +5 more
wiley   +1 more source

Mechanisms of TRAIL-resistance:novel targets to enhance TRAIL sensitization for cancer therapy [PDF]

open access: yes, 2020
TRAIL has been shown to target tumor cells but not healthy cells in vitro. In addition, clinical studies have revealed that recombinant human TRAIL is well tolerated in patients.
Zhang, Baojie
core   +2 more sources

Lactylation of HDAC1 Confers Resistance to Ferroptosis in Colorectal Cancer

open access: yesAdvanced Science, Volume 12, Issue 12, March 27, 2025.
HDAC inhibitor decreases HDAC1K412 lactylation to sensitize colorectal cancer to ferroptosis and the combination of HDAC inhibitor and ferroptosis inducers can be a promising therapeutic strategy for colorectal cancer. Abstract Colorectal cancer (CRC) is highly resistant to ferroptosis, which hinders the application of anti‐ferroptosis therapy. Through
Zhou Yang   +17 more
wiley   +1 more source

HDAC3 in action: Expanding roles in inflammation and inflammatory diseases

open access: yesCell Proliferation, Volume 58, Issue 1, January 2025.
HDAC3, a member of the histone deacetylase (HDAC) superfamily, is involved in the regulation of acetylation/deacetylation processes associated with inflammation‐related diseases. This article reviews the key role of HDAC3 in the process of inflammation, the potential molecular mechanism and the clinical significance of targeted therapy.
Ruyuan He   +6 more
wiley   +1 more source

HDAC3 inhibition prevents blood-brain barrier permeability through Nrf2 activation in type 2 diabetes male mice

open access: yesJournal of Neuroinflammation, 2019
Background Type 2 diabetes mellitus (T2DM) is a chronic metabolic dysfunction characterized by progressive insulin resistance and hyperglycaemia. Increased blood-brain barrier (BBB) permeability is a critical neurovascular complication of T2DM that ...
Qiuchen Zhao   +8 more
doaj   +1 more source

HDAC1 is a Required Cofactor of CBFβ-SMMHC and a Therapeutic Target in Inversion 16 Acute Myeloid Leukemia [PDF]

open access: yes, 2019
Acute myeloid leukemia (AML) is a neoplastic disease characterized by the uncontrolled proliferation and accumulation of immature myeloid cells. A common mutation in AML is the inversion of chromosome 16 [inv(16)], which generates a fusion between the ...
Richter, Lisa E
core   +1 more source

Histone Deacetylase Inhibitors Prevent Pulmonary Endothelial Hyperpermeability and Acute Lung Injury By Regulating Heat Shock Protein 90 Function [PDF]

open access: yes, 2015
Transendothelial hyperpermeability caused by numerous agonists is dependent on heat shock protein 90 (Hsp90) and leads to endothelial barrier dysfunction (EBD). Inhibition of Hsp90 protects and restores transendothelial permeability.
Atul D. Joshi   +15 more
core   +2 more sources

Recent Developments and Evolving Therapeutic Strategies in KMT2A‐Rearranged Acute Leukemia

open access: yesCancer Medicine, Volume 13, Issue 20, October 2024.
ABSTRACT Background Rearrangements of the histone‐lysine‐N‐methyltransferase (KMT2A), previously referred to as mixed‐lineage leukemia (MLL), are among the most common chromosomal abnormalities in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), involving numerous different fusion partners.
Lei Yin   +4 more
wiley   +1 more source

The effect of butyrate on human macrophages:Immunomodulation and Epigenetic Regulation [PDF]

open access: yes
Butyrate is a short-chain fatty acid produced by gut microbiota during the fermentation of dietary fibers. Its concentration varies across regions of the body, especially in the gut.
Jiang, Muwei
core   +1 more source

Home - About - Disclaimer - Privacy